The body weight, liver weight, and plasma ALT and AST levels were not changed by CHCHD2 deletion in the NASH mouse model (Supplemental Figure 3A and Figure 3B). This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.